tenk.fyi

Q/C TECHNOLOGIES, INC.

QCLSNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

-

Net Income

-$23.4M

484.0% YoY

EPS

$-11.15

109.2% YoY

Cash

$173,154

93.5% YoY

FY 2024 · As of 2024-12-31